Related references
Note: Only part of the references are listed.Donor to recipient transmission of SARS-CoV-2 by lung transplantation despite negative donor upper respiratory tract testing
Daniel R. Kaul et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2021)
The impact of COVID-19 on kidney transplantation and the kidney transplant recipient - One year into the pandemic
Pascale Khairallah et al.
TRANSPLANT INTERNATIONAL (2021)
SARS Coronavirus-2 Microneutralisation and Commercial Serological Assays Correlated Closely for Some but Not All Enzyme Immunoassays
Gregory J. Walker et al.
VIRUSES-BASEL (2021)
The solid organ transplant recipient with SARS-CoV-2 infection
Justin C. Laracy et al.
CURRENT OPINION IN ORGAN TRANSPLANTATION (2021)
Serological testing for infectious diseases markers of donor specimens from 24 h after death show no significant change in outcomes from other specimens
Chee Choy Kok et al.
CELL AND TISSUE BANKING (2020)
Donor and transplant candidate selection for solid organ transplantation during the COVID-19 pandemic
N. Thao N. Galvan et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2020)
A single center observational study lb Check of the clinical characteristics and short-term outcome of 20 kidney transplant patients admitted for SARS-CoV2 pneumonia
Federico Alberici et al.
KIDNEY INTERNATIONAL (2020)
Evaluation of SARS-CoV-2 serology assays reveals a range of test performance
Jeffrey D. Whitman et al.
NATURE BIOTECHNOLOGY (2020)
Infectious disease screening of blood specimens collected post-mortem provides comparable results to pre-mortem specimens
Cristina Baleriola et al.
CELL AND TISSUE BANKING (2012)
A prospective time-course study on serological testing for human immunodeficiency virus, hepatitis B virus and hepatitis C virus with blood samples taken up to 48 h after death
Carolin Edler et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2011)
Screening of blood from potential organ and cornea donors for viruses
M Miédougé et al.
JOURNAL OF MEDICAL VIROLOGY (2002)